FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnology and virology. Novel recombinant polypeptide of influenza virus, representing haemagglutin, is claimed. Described polypeptide can be used for obtaining novel recombinant reassortant strains of influenza virus. Invention can be used in medicine.
EFFECT: described are: recombinant nucleic acid, coding such polypeptide, method of obtaining reassortant influenza viruses, reassortant influenza virus and thereof-containing compositions.
16 cl, 9 dwg, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CHIMERIC INFLUENZA VACCINES | 2021 |
|
RU2834969C1 |
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| SWINE INFLUENZA VIRUS VACCINE CONTAINING NUCLEIC ACID CONSTRUCT HAVING SPECIFIC GENE ORDER | 2021 |
|
RU2833693C1 |
| SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT COMPRISING FIRST, SECOND AND THIRD NUCLEIC ACID SEQUENCES ENCODING DIFFERENT ANTIGENS, NEURAMINIDASE, VIRUS | 2021 |
|
RU2841382C1 |
| SWINE INFLUENZA VIRUS VACCINE CONTAINING TWO DIFFERENT RNA REPLICON PARTICLES | 2021 |
|
RU2839757C1 |
| ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS | 2021 |
|
RU2813150C2 |
| INFLUENZA HEMAGGLUTININ COMPOSITIONS WITH HETEROLOGOUS EPITOPES AND/OR ALTERED CLEAVAGE SITES DURING MATURATION | 2017 |
|
RU2769406C2 |
| VACCINE TO SWINE INFLUENZA A VIRUS | 2018 |
|
RU2787596C2 |
| NEUTRALIZING ANTIBODIES TO INFLUENZA VIRUS B AND WAYS OF THEIR APPLICATION | 2015 |
|
RU2739952C2 |
| NEUTRALIZING ANTIBODIES AGAINST THE INFLUENZA A VIRUS AND WAYS OF THEIR APPLICATION | 2014 |
|
RU2803850C2 |
